Dialysis Patient Count measures the number of patients served by DaVita's U.S. dialysis business at period end.
DaVita reported approximately 200,500 U.S. patients in its 2025 disclosures.
Annual treatment volume was about 143 treatments per patient
DaVita reported 28,733,980 U.S. dialysis treatments.
Dividing treatment volume by 200,500 patients gives approximately 143 treatments per patient per year as a broad activity-density measure.
Patient count and market share imply a roughly 557,000-patient U.S. market
DaVita estimated approximately 36% U.S. market share by patients served.
Dividing 200,500 by 36% implies a market of about 557,000 patients, but this is only a rough inversion of DaVita's own market-share estimate.
Use Dialysis U.S. Market Share for the issuer-estimated share.
Patient count is not annual unique-patient flow
Starts, deaths, transplants, transfers, and modality changes can make a point-in-time patient count differ from annual unique patients treated.
Primary source: DaVita 2025 Form 10-K.
Part of the Dialysis Provider Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- DVAOpen operating-model research →17 of 17 reviewed concepts in Dialysis Provider EconomicsTreatment volume, patient base, and network footprint8 of 8 bridge concepts supportedContinue through this bridge:Dialysis Average Treatments per DayDialysis Hospital Service Contract CountDialysis Normalized Non-Acquired Treatment GrowthDialysis Outpatient Center CountDialysis Treatment DaysDialysis Treatment VolumeDialysis U.S. Market Share
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare public companies
Compare patient population with annual treatments, center density, and DaVita's patient-based market-share estimate.
Explore more topics in the Financial Research Encyclopedia.